Tissue microarrays from renal cell tumors: exclusion criteria and rate of exclusion

Martina Hager1, Christian Kolbitsch, Werner Tiefenthaler

  • 1Department of Pathology, Paracelsus Medical University, Salzburg, Austria. hager.martina@gmx.at

Abstract

Insights

To minimize data loss in tissue microarray (TMA) studies, researchers should use at least three to four cores per case, especially for renal cell tumors. Punching fewer cores significantly increases the risk of losing entire tumor cases from analysis.

Area of Science:

  • Oncology
  • Pathology
  • Biomedical Research

Background:

  • Tissue microarrays (TMAs) are crucial for large-scale studies, but core exclusion can lead to the loss of entire tumor cases.
  • This loss can negatively impact the reliability and statistical power of TMA-based research findings.
  • Understanding core exclusion rates and reasons is vital for optimizing TMA construction.

Purpose of the Study:

  • To evaluate the loss of informative cores when a specific number of slices are cut from a TMA block.
  • To investigate how core exclusion rates vary across different subtypes of renal cell tumors.
  • To identify the detailed reasons contributing to the loss of informative cores.

Main Methods:

  • A tissue microarray (TMA) was constructed using 461 renal tumor specimens.
  • The exclusion rate and causes were assessed in the first slice (FS) and the 40th slice (LS) of TMA blocks.
  • Overall case loss was extrapolated based on punching one, two, or three cores per case.

Main Results:

  • Sarcomatoid and papillary renal cell carcinomas exhibited the highest exclusion rates.
  • Case loss approximately tripled from the first slice to the last slice, irrespective of tumor type.
  • Reducing the number of cores per case, e.g., by one, could double the number of lost cases. Common exclusion reasons included core loss, insufficient tumor tissue (<25%), core folding, and necrotic tissue.

Conclusions:

  • Punching a minimum of three to four cores per case is recommended for constructing TMAs from oncocytoma and renal cell carcinoma specimens.
  • The specific tumor type influences the causes and rates of core exclusion.
  • Optimizing core selection is essential to prevent case loss and ensure robust TMA study outcomes.

Related Concept Videos